Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Clinical Trials 94
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 87
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,382 Results (Page 50 of 120)
- Relevance
  Sort by

Cardiovascular Collaboration and Licensing Deals 2016-2025

 Report
October 2025
300 Pages
Global

From

€3485EUR$3,995USD£3,035GBP

Systematic Lupus Erythematosus Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
111 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Type 2 Diabetes Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

 Report
April 2022
85 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Pancreatic Cancer Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3917EUR$4,490USD£3,411GBP

T-cell Lymphoma Market 2024-2028

 Report
August 2024
135 Pages
Global

From

€2181EUR$2,500USD£1,899GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Psoriasis Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
196 Pages
Global

From

€3436EUR$3,939USD£2,992GBP

Vaccine Contract Manufacturing Market: Industry Trends and Global Forecasts to 2035: Type of Expression System Used (Mammalian, Microbial and Others), Company Size and Geographical Region

 Report
August 2024
381 Pages
Global

From

€4186EUR$4,799USD£3,646GBP

Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028

 Report
July 2024
190 Pages
Global

From

€2181EUR$2,500USD£1,899GBP

Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Regional Outlook and Forecast, 2022 - 2028

 Report
November 2022
226 Pages
Global

From

€3140EUR$3,600USD£2,735GBP

Pancreatic Cancer Treatment Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3620EUR$4,150USD£3,153GBP

Apremilast Tablets Market - Global Forecast 2025-2030

 Report
August 2025
184 Pages
Global

From

€3436EUR$3,939USD£2,992GBP

Dendritic Cell Cancer Vaccine Market Size, Share & Trends Analysis Report By Products (CreaVax, Sipuleucel-T), By End-use (Pediatrics, Adults), By Region, And Segment Forecasts, 2023 - 2030

 Report
November 2022
200 Pages
Global

From

€5190EUR$5,950USD£4,520GBP

Chronic Myelogenous Leukemia Therapeutics Market 2024-2028

 Report
October 2024
146 Pages
Global

From

€2181EUR$2,500USD£1,899GBP

Prostate Cancer Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
188 Pages
Global

From

€3436EUR$3,939USD£2,992GBP

Ulcerative Colitis (UC) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031

 Drug Pipelines
March 2023
125 Pages
Global

From

€13080EUR$14,995USD£11,391GBP

Unresectable Hepatocellular Carcinoma Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3917EUR$4,490USD£3,411GBP

Cholangiocarcinoma- Pipeline Insight, 2025

 Clinical Trials
April 2025
210 Pages
Global

From

€2181EUR$2,500USD£1,899GBP

Hepatoblastoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
180 Pages
Global

From

€3925EUR$4,500USD£3,419GBP

Pancreatic Cancer Diagnostic Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3917EUR$4,490USD£3,411GBP

Pancreatic Ductal Adenocarcinoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
200 Pages
Global

From

€2617EUR$3,000USD£2,279GBP

2,382 Results (Page 50 of 120)
- 1
- 48
- 49
- 50
- 51
- 52

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.